Tag: brokerswatch

Sep 12
Gilead’s stock jumps 5% after setting patent case related to HIV therapies

Shares of Gilead Sciences Inc. GILD, +4.91% were up 5.2% in premarket trading on Monday after the company said in a securities filing that it settled a patent case that extends the exclusivity of its HIV franchise. The drug cited in the case is tenofovir alafenamide, which is included in the formulation of several Gilead […]

Sep 12
Pizza Hut parent Yum Brands board approves new up to $2 billion share buyback

Yum Brands Inc. YUM, +1.86% said Monday its board has approved a share buyback program of up to $2 billion to be valid through June 30 of 2024. The operator of KFC, Taco Bell and Pizza Hut restaurants, said the authorization will take effect once its current program has been exhausted. The company still has […]

Sep 12
Target announces multiyear agreement with FAO Schwarz for its toys to feature exclusively at Target stores

Target Corp. TGT, +0.69% said Monday it has entered a multiyear agreement with toy maker FAO Schwarz that will allow it to exclusively feature FAO’s toys at its stores, on Target.com and at FAO store locations starting in October. The company said all of its toy departments will have dedicated space for FAO Schwarz, and […]

Sep 12
U.S. IPO market braces for biggest deal of the year in AIG unit Corebridge Financial’s $1.8 billion offering

The U.S. initial public offering market is bracing for what’s expected to be the biggest deal of the year so far, that of the spin-off of AIG’s AIG, +1.31% life insurance unit Corebridge Financial CRBG, , which is aiming to raise $1.8 billion. “At the expected deal size it’ll represent over a quarter of all […]

Sep 12
Cable One stock downgraded as Wells Fargo sees various pressures on cable industry

Wells Fargo analyst Steven Cahall downgraded shares of Cable One Inc. CABO, +2.10% to equal-weight from overweight Monday, warning of the spending trajectory ahead for the broader cable universe. “While we think CABO has the strongest/best network-nearly 70% fiber by mileage-it’s also well known that incremental competition is coming to all areas, including rural,” Cahall […]

Sep 12
JPMorgan Chase buys cloud payments company Renovite Technologies

JPMorgan Chase & Co. JPM, +0.48% said Monday it’s paying an undisclosed sum to acquire Renovite Technologies Inc., a privately-held cloud payments technology company based in Fremont, Calif. and founded in 2015. Renovite Technologies has been a service provider to JPMorgan since 2021. Max Neukirchen, global head of payments and Commerce Solutions at JPMorgan, said […]

Sep 12
GE confirms on track for spinoff of GE HealthCare the first week of Jan. 2023

General Electric Co. GE, +0.37% said Monday it’s on track for the targeted spinoff of GE HealthCare the first week of Jan. 2023. The company said it would create a board of directors for the business following the spinoff. GE Chairman and CEO Lawrence Culp will be non-executive chairman of the new company, while Peter […]

Sep 12
AmerisourceBergen agrees to acquire Germany’s PharmaLex for 1.28 billion euros in cash

AmerisourceBergen Corp. ABC, -0.18% said Monday it has agreed to acquire PharmaLex Holding GmbH, a German company offering specialized services for the life sciences industry, or 1.28 billion euros ($1.29 billion) in cash. The deal “will advance AmerisourceBergen’s role as partner of choice for biopharmaceutical manufacturers by enhancing AmerisourceBergen’s global portfolio of solutions to support […]

Sep 12
Coronavirus tally: U.S. known cases fall to lowest level seen since early May

U.S. known cases of COVID are continuing to ease and now stand at their lowest level since early May, although the true tally is likely higher given how many people are testing at home, where the data are not being collected. The daily average for new cases stood at 66.159 on Sunday, according to a […]

Sep 12
Bristol Myers Squibb rallies after FDA approves Sotyktu for psoriasis

Bristol Myers Squibb BMY, +1.12% shares rose 7% in premarket trade after the company said the U.S. Food and Drug Administration approved Sotyktu, which the drugmaker said was the first innovation in oral treatment for moderate-to-severe plaque psoriasis in nearly 10 years. Bristol Myers Squibb said the approval came after Phase 3 trials found it […]